New Delhi [India], May 27 (ANI): Dismissing the reports of health risks from Hydroxychloroquine (HCQ) as per simmering reports cited by the World Health Organisation (WHO), Shekher Mande, Director General of the Council of Scientific and Industrial Research (CSIR), India, said on Wednesday t
New Delhi [India], May 26 (ANI): Noting that a lot of drugs are being repurposed for treatment of COVID-19, ICMR Director-General Dr Balram Bhargava on Tuesday said that prophylactic use of Hydroxychloroquine (HCQ) for health care workers had been recommended on the basis of risk-benefit a
New Delhi [India], May 26 (ANI): Health Ministry of India has written to the World Health Organisation (WHO) after the global health body announced to temporarily suspend the clinical trials of Hydroxychloroquine (HCQ) for the treatment of COVID-19 patients, sources told ANI.
New Delhi [India], May 26 (ANI): Dr Randeep Guleria, Director, All India Institute of Medical Sciences (AIIMS), New Delhi, on Tuesday said that 'judicious, and appropriate' use of hydroxychloroquine (HCQ) as a standalone drug should not pose any health risks in COVID-19 cases.
New Delhi, [India], May 26 (ANI): The Union Health Ministry has directed all States and Union Territories (UTs) to update the availability and consumption of hydroxychloroquine or HCQ tablets on the national COVID-19 portal as real-time data. The Ministry said that this will help it to chalk
Geneva [Switzerland], May 26 (ANI): The World Health Organisation (WHO) on Monday (local time) temporarily suspended the clinical trial of malarial drug hydroxychloroquine for the treatment of coronavirus.
New Delhi [India], May 22 (ANI): After some promising results on the efficacy of prophylactic use of Hydroxychloroquine (HCQ) against COVID-19 infection, the Central government has expanded the use of the medicine as prophylaxis to healthcare and other frontline workers deployed in non-CO
New Delhi [India], May 22 (ANI): The Central government has revised the advisory on the use of Hydroxychloroquine (HCQ) as prophylactic for COVID-19 infection, expanding the use of the medicine for asymptomatic healthcare and frontline workers deployed in non-COVID and COVID areas.
New Delhi [India], May 20 (ANI): An interim report prepared by the Telangana government has yielded promising results on the efficacy of prophylactic use of Hydroxychloroquine or HCQ, as it is popularly known, on preventing COVID-19 in frontline medical workers in the state.
Washington D.C. [US], May 20 (ANI): US President Donald Trump on Tuesday continued to defend his decision to take hydroxychloroquine saying he believes that it gives an additional level of safety.
New Delhi [India], May 19 (ANI): At least five hospitals across India have registered for a twelve week-long observational study on hydroxychloroquine (HCQ) being conducted by the Indian Council Medical Research (ICMR).
Washington D.C. [USA], May 19 (ANI): House Speaker Nancy Pelosi on Monday criticized President Donald Trump for taking hydroxychloroquine--an anti-malarial drug which is believed to be helpful in keeping away from coronavirus infection but has not been approved by scientists, adding that he